Saturday 17 October 2026
Export OPK’s income statement to Excel — free account
OPKO Health, Inc.
OPK Healthcare Diagnostics & Research
OPKO Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.9 million, down 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS grew 94.7%, free cash flow grew 46.5% and total debt rose 6.37%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.53
0.08
−4.97%
Follow OPK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (5.88%) | (16.92%) | (17.14%) | (13.32%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
2 | 3 | 4 | 3 | |
| (3.83%) | (10.69%) | (10.92%) | (8.49%) | ||
ROIC |
(2.45%) | (5.25%) | (5.91%) | (5.75%) | |
Return on Tangible Assets |
(17.26%) | (46.33%) | (44.33%) | (33.86%) | |
Average Days of Receivables |
50.84 | 50.02 | 54.28 | 53.77 | |
Free Cash Flow per Share |
(0.18) | (0.23) | (0.25) | (0.27) | |
Free Cash Flow |
(133.73) | (173.96) | (190.53) | (211.79) | |
Capital Expenditures |
(10.35) | (10.66) | (11.99) | (14.76) | |
| Other line items | |||||
Cash ROIC |
(7.30%) | (9.20%) | (9.63%) | (10.33%) | |
Accounts Receivable Turnover |
6.49 | 6.61 | 5.83 | 6.38 | |
Accounts Payable Turnover |
6.53 | 7.19 | 9.09 | 7.32 | |
Inventory Turnover |
5.43 | 5.80 | 6.54 | 6.68 | |
Average Days of Payables |
52.46 | 43.34 | 37.42 | 44.65 | |
Days of Inventory on Hand |
64.83 | 63.18 | 59.92 | 57.06 | |
Tax Rate |
(0.09) | (0.07) | (0.07) | 0.13 | |
Research and Development Expense of Revenue |
21.30% | 21.06% | 20.44% | 18.95% | |
Selling, General and Administrative Expense of Revenue |
35.01% | 36.57% | 36.75% | 37.30% | |
Share Based Compensation of Revenue |
1.85% | 1.86% | 1.77% | 1.69% | |
Interest Coverage |
(1.07) | (0.97) | (1.08) | (1.01) | |
Operating CF/Net income |
1.69 | 0.77 | 0.79 | 1.09 | |
Depreciation/Fixed assets |
1.26 | 1.31 | 1.31 | 1.32 | |
Capex/Depreciation |
(0.11) | (0.11) | (0.12) | (0.15) | |
Revenue per Share |
0.78 | 0.77 | 0.81 | 0.83 | |
Operating CF per Share |
(0.16) | (0.22) | (0.24) | (0.25) | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.02) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates